# Safety and Tolerability Study With Single Ascending Doses of ORM-12741

> **NCT00693316** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 120 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ORM-12741

## Key facts

- **NCT ID:** NCT00693316
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2010-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693316, "Safety and Tolerability Study With Single Ascending Doses of ORM-12741". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00693316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*